Today, July 23, a panel of advisers to the FDA voted to place a widely used peptide called #BPC157 on a list that would allow broader pharmacy #compounding BPC-157 is a synthetic #peptide that promotes the growth of new blood vessels and collagen production, which may speed the recovery time of injured muscles, tendons, and ligaments
For a broader primer on how BPC-157 works and what the evidence supports, see BPC-157 Peptide Benefits: The Recovery Compound Moving from Bodybuilding to Mainstream Medicine
Typical experimental endpoints include measures of collagen and extracellular matrix protein expression, cell migration rates, cytoskeletal organization, and transcriptional changes in genes related to tissue structure and repair, depending on the model
We also do not believe that PreciseBreast test qualifies as an exception to the OPPS laboratory packaging policy based on criteria discussed in the Laboratory Related Services section
May your peptides stay stable, your protocols stay precise, and your healing stay consistent.
Therapy Effect of Antiulcer Agents
